Journal of Cancer Research and Therapeutics Close
 

Figure 8: Kidney IHC-Bcl-2: (a) Control untreated rats: very intense cytoplasmic staining of tubular epithelium. (b) BME-treated rats: moderate tubular cytoplasmic staining. (c) Cisplatin-treated rats: weak tubular cytoplasmic staining. (d) Cisplatin and BME treatment reduces the intensity of staining (×400)

Figure 8: Kidney IHC-Bcl-2: (a) Control untreated rats: very intense cytoplasmic staining of tubular epithelium. (b) BME-treated rats: moderate tubular cytoplasmic staining. (c) Cisplatin-treated rats: weak tubular cytoplasmic staining. (d) Cisplatin and BME treatment reduces the intensity of staining (×400)